Rafael Holdings Inc - Class B

RFL NYSE Healthcare & Biotech United States US75062E1064
2.24 $
5.66 %

Rafael Holdings Inc develops and invests in biotechnology and medical companies, particularly in the field of oncology.

Performance & Momentum

6 Months 57.53 %
1 Year 4.55 %
3 Years 13.77 %
5 Years 94.68 %

Strategic Analysis

Rafael Holdings Inc - Class B is a holding company focused on investments at the intersection of healthcare, biotechnology, and real estate. Its positioning relies less on operating a single industrial business than on the valuation of a portfolio of assets and thematic exposures, with an unusual profile in the U.S. small-cap universe.

Strengths
  • Diversified exposure across several asset pools, which limits dependence on a single operating revenue stream
  • Original positioning in healthcare and biotechnology, two long-term structural themes
  • Presence of real estate assets that can provide a more tangible asset base
Weaknesses
  • A holding company model is often opaque for investors, with limited visibility on the real creation of value
  • Structurally weak stock performance, suggesting persistent market distrust
Momentum

Momentum remains weak despite a slight recent improvement, which mainly reflects a technical rebound after a very negative underlying trend. The strategic read remains cautious: the stock may attract speculative investors looking for a discount or an asset reallocation catalyst, but the lack of a real fundamental turning point keeps the risk profile elevated.

Similar stocks to Rafael Holdings Inc - Class B

Anantys Community

Be the first to share your analysis on Rafael Holdings Inc - Class B.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases